|Other names||CDB-4730; Dimethandrolone dodecanoylcarbonate; Dimethandrolone 17β-dodecylcarbonate; 7α,11β-Dimethyl-19-nortestosterone 17β-dodecylcarbonate|
|By mouth, intramuscular injection|
|Drug class||Androgen; Anabolic steroid; Progestogen|
|Chemical and physical data|
|Molar mass||514.791 g·mol−1|
|3D model (JSmol)|
Dimethandrolone dodecylcarbonate (developmental code name CDB-4730), or dimethandrolone dodecanoylcarbonate, also known as 7α,11β-dimethyl-19-nortestosterone 17β-dodecylcarbonate, is a synthetic and orally active anabolic–androgenic steroid (AAS) and a derivative of nandrolone (19-nortestosterone) which was developed by the Contraceptive Development Branch (CDB) of the National Institute of Child Health and Human Development (NICHD) and has not been marketed at this time. It is an androgen ester – specifically, the C17β dodecylcarbonate ester of dimethandrolone (7α,11β-dimethyl-19-nortestosterone) – and acts as a prodrug of dimethandrolone in the body.
- Blye, Richard P., and Hyun K. Kim. "Nandrolone 17β-carbonates." U.S. Patent No. 7,820,642. 26 Oct. 2010.
|This article about a steroid is a stub. You can help Wikipedia by expanding it.|
|This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it.|